Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus

World Journal of Gastroenterology

Volumn 21, Issue 32, 2015, Pages 9607-9613

  Li, Wei Dong ^a   Fu, Kun Fa ^b   Li, Gui Mei ^c   Lian, Yan Shu ^d   Ren, Ai Min ^e   Chen, Yun Jue ^f   Xia, Jin Rong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b Jiangsu Provincial Geriatric Hospital   (China)

^c Nanjing Liberation Army 81 Hospital   (China)

^d Jiankang Vocational College   (China)

^e NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^f Nanjing Occupational Disease Prevention and Control Hospital   (China)

Author keywords

Cohort study; Incidence; Non alcoholic fatty liver disease; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLUCOSE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; B SCAN; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHINESE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; HEALTH SURVEY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR;

ADULT; AGED; BODY MASS INDEX; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84940121986     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i32.9607     Document Type: Article

References (33)

1. An R. Prevalence and Trends of Adult Obesity in the US, 1999-2012. ISRN Obes 2014; 2014: 185132 [PMID: 25002986 DOI: 10.1155/2014/185132]
2. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497 [PMID: 22253363 DOI: 10.1001/jama.2012.39]
3. Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level. BMC Public Health 2014; 14: 143 [PMID: 24512151 DOI: 10.1186/147 1-2458-14-143]
4. Ning X, Zhan C, Yang Y, Yang L, Tu J, Gu H, Su TC, Wang J. Secular trends in prevalence of overweight and obesity among adults in rural Tianjin, China from 1991 to 2011: a populationbased study. PLoS One 2014; 9: e116019 [PMID: 25544990 DOI: 10.1371/journal.pone.0116019]
5. de Mutsert R, Sun Q, Willett WC, Hu FB, van Dam RM. Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study. Am J Epidemiol 2014; 179: 1353-1365 [PMID: 24786797 DOI: 10.1093/aje/kwu052]
6. Nora M, Guimarães M, Almeida R, Martins P, Gonçalves G, Santos M, Morais T, Freitas C, Monteiro MP. Excess body mass index loss predicts metabolic syndrome remission after gastric bypass. Diabetol Metab Syndr 2014; 6: 1 [PMID: 24383616 DOI: 10.1186/1758-5996-6-1]
7. Palaniappan LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. Int J Obes (Lond) 2011; 35: 393-400 [PMID: 20680014 DOI: 10.1038/ijo.2010.152]
8. Zhang H, Rodriguez-Monguio R. Racial disparities in the risk of developing obesity-related diseases: a cross-sectional study. Ethn Dis 2012; 22: 308-316 [PMID: 22870574]
9. Shao J, Yu L, Shen X, Li D, Wang K. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J Nutr Health Aging 2010; 14: 782-785 [PMID: 21085910]
10. Liu Y, Tong G, Tong W, Lu L, Qin X. Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects? BMC Public Health 2011; 11: 35 [PMID: 21226967 DOI: 10.1186/1471-2458-11-35]
11. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438 [PMID: 7382552]
12. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023 [PMID: 22488764 DOI: 10.1002/hep.25762]
13. Caldwell S, Argo C. The natural history of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 162-168 [PMID: 20460906 DOI: 10.1159/000282081]
14. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007; 22: 788-793 [PMID: 17565631 DOI: 10.1111/j.1440-1746.2007.05042.x]
15. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112 [PMID: 16447287 DOI: 10.1002/hep.20973]
16. Larter CZ, Chitturi S, Heydet D, Farrell GC. A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 2010; 25: 672-690 [PMID: 20492324 DOI: 10.1111/j.1440-1746.2010.06253.x]
17. Ryoo JH, Choi JM, Moon SY, Suh YJ, Shin JY, Shin HC, Park SK. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year' s prospective cohort study. Atherosclerosis 2013; 227: 398-403 [PMID: 23390894 DOI: 10.1016/j.atherosclerosis]
18. Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, Hardies J, Cusi K. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 2012; 35: 873-878 [PMID: 22374640 DOI: 10.2337/dc11-1849]
19. Kasturiratne A, Weerasinghe S, Dassanayake AS, Rajindrajith S, de Silva AP, Kato N, Wickremasinghe AR, de Silva HJ. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol 2013; 28: 142-147 [PMID: 22989165 DOI: 10.1111/j.1440-1746.2012.07264.x]
20. Zelber-Sagi S, Lotan R, Shibolet O, Webb M, Buch A, Nitzan- Kaluski D, Halpern Z, Santo E, Oren R. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Liver Int 2013; 33: 1406-1412 [PMID: 23656177 DOI: 10.1111/liv.12200]
21. Hu X, Huang Y, Bao Z, Wang Y, Shi D, Liu F, Gao Z, Yu X. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol 2012; 12: 123 [PMID: 22978800 DOI: 10.1186/1471-230X-12-123]
22. Liao XH, Cao X, Liu J, Xie XH, Sun YH, Zhong BH. Prevalence and features of fatty liver detected by physical examination in Guangzhou. World J Gastroenterol 2013; 19: 5334-5339 [PMID: 23983438 DOI: 10.3748/wjg.v19.i32.5334]
23. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777 [PMID: 17565629]
24. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 2006; 163: 1042-1052 [PMID: 16611666]
25. Ganz ML, Wintfeld N, Li Q, Alas V, Langer J, Hammer M. The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States. Diabetol Metab Syndr 2014; 6: 50 [PMID: 24694251 DOI: 10.1186/1758-5996-6-50]
26. Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6: 263-273 [PMID: 24868320 DOI: 10.4254/wjh.v6.i5.263]
27. Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 2004; 17 Suppl: 1-36 [PMID: 15807475]
28. Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014; 510: 84-91 [PMID: 24899308 DOI: 10.1038/ nature13478]
29. Arase Y, Suzuki F, Ikeda K, Kumada H, Tsuji H, Kobayashi T. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J Gastroenterol 2009; 44: 1064-1070 [PMID: 19533014 DOI: 10.1007/s00535-009-0091-1]
30. Chon CW, Kim BS, Cho YK, Sung KC, Bae JC, Kim TW, Won HS, Joo KJ. Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men. Gut Liver 2012; 6: 368-373 [PMID: 22844567 DOI: 10.5009/ gnl.2012.6.3.368]
31. Ming J, Xu S, Gao B, Liu G, Ji Y, Yang F, Jia Y, Fang Y, Ji Q. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study. Liver Int 2015; Epub ahead of print [PMID: 25879672 DOI: 10.1111/ liv.12851]
32. Boppidi H, Daram SR. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome. Postgrad Med 2008; 120: E01-E07 [PMID: 18654060 DOI: 10.3810/ pgm.2008.07.1800]
33. Da Silva HE, Arendt BM, Noureldin SA, Therapondos G, Guindi M, Allard JP. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet 2014; 114: 1181-1194 [PMID: 24631112 DOI: 10.1016/j.jand.2014.01.009]